We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUPV:NYSEGrupo Supervielle S.A. Analysis

Data as of 2026-05-03 - not real-time

$7.89

Latest Price

8/10Risk

Risk Level: High

Executive Summary

SUPV trades at $7.89, hugging the computed support of $7.66, with a 30‑day RSI of ~30 indicating oversold conditions. The MACD histogram is negative and the signal line is bearish, suggesting short‑term momentum weakness. However, volatility is extreme at 62% over the past month and beta exceeds 2.5, flagging heightened sensitivity to market swings. The forward P/E of 5.98 is well below the industry average of 17.5, while the DCF model projects a fair value of over $43,000 per share, implying a theoretical upside of more than 60%. Recent filings show the company submitted its 2025 Form 20‑F and the Q4 earnings call disclosed a net loss that, while still sizable, improved markedly from the prior quarter.
The balance sheet holds over $670 billion in cash against $1.13 trillion of debt, giving a zero‑debt‑to‑equity ratio but a stressed leverage profile. No dividend is paid, eliminating income yield. Analyst consensus is a “hold” with a median price target around $13, far below the DCF estimate. Given the combination of deep valuation discount, improving earnings outlook, and substantial liquidity, the stock presents a speculative upside if macro‑economic conditions in Argentina stabilize. Nonetheless, the high beta, acute volatility, and sovereign risks keep the risk profile elevated.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Oversold RSI near 30
  • Price at technical support
  • Extreme short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF implied upside >60%
  • Forward P/E well below industry
  • Improving earnings trajectory

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Large cash buffer versus debt
  • Potential macro‑economic stabilization in Argentina
  • Significant valuation gap to fair value

Key Metrics & Analysis

Financial Health

Revenue Growth-29.80%
Profit Margin-6.66%
P/E Ratio6.0
ROE-4.66%
ROA-0.71%
P/B Ratio1.0
Op. Cash Flow$489.1B
Industry P/E17.5

Technical Analysis

TrendNeutral
RSI30.7
Support$7.66
Resistance$10.14
MA 20$9.31
MA 50$9.12
MA 200$9.50
MACDBearish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

Fair Value$43,421.55
Target Price$12.80
Upside/Downside62.25%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.55
Volatility62.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.